Zevra Therapeutics Inc

Zevra Therapeutics Inc

KMPH - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$345.16M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Zevra Therapeutics IncZevra Therapeutics Inc7.1-33%2.90.1
$34.03

Current Fair Value

485.7% upside

Undervalued by 485.7% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$345.16 Million
Enterprise Value$242.77 Million
Earnings per Share$1.4
Beta2.16
Outstanding Shares59,407,392

Return

Return on Equity33.02%ROE
Return on Assets25.16%
Return on Invested Capital33.14%

Valuation & Multiples

P/E Ratio7.09P/E Ratio
PEG-0.49PEG
Price to Sales2.91Price to Sales
Price to Book Ratio1.45Price to Book Ratio
Enterprise Value to Revenue1.64
Enterprise Value to EBIT2.69
Enterprise Value to Net Income3
Total Debt to Enterprise0.08
Debt to Equity0.08Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About KemPharm Inc

22 employees
CEO: Travis Mickle

KemPharm is a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs to treat serious medical conditions through its proprietary LAT™ (Ligand Activated Therapy) technology. KemPharm utilizes its...

Zevra Therapeutics Insider Information FAQ

Stockcircle tracks 4 top investors with a current 13F position in Zevra Therapeutics. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.